COVID-19 among Malaysian patients with systemic lupus erythematosus on hydroxychloroquine.

作者信息

Teh Cheng Lay, Cheong Yaw Kiet, Wan Musa Wan Rosmaiza, Wan Mohd Akbar Sharifah Aishah, Mat Husin Noraini, Gun Suk Chyn

机构信息

Department of Medicine, Sarawak General Hospital, Kuching, Sarawak, Malaysia

Department of Medicine, Sarawak General Hospital, Kuching, Sarawak, Malaysia.

出版信息

Ann Rheum Dis. 2021 May;80(5):e69. doi: 10.1136/annrheumdis-2020-218154. Epub 2020 Jul 31.

DOI:10.1136/annrheumdis-2020-218154

PMID:32737111

Abstract

摘要

相似文献

COVID-19 among Malaysian patients with systemic lupus erythematosus on hydroxychloroquine.

Ann Rheum Dis. 2021 May;80(5):e69. doi: 10.1136/annrheumdis-2020-218154. Epub 2020 Jul 31.

Response to: 'COVID-19 among Malaysian patients with systemic lupus erythematosus on hydroxychloroquine' by Teh .

Ann Rheum Dis. 2021 May;80(5):e70. doi: 10.1136/annrheumdis-2020-218173. Epub 2020 Jul 31.

Hydroxychloroquine shortages among patients with systemic lupus erythematosus during the COVID-19 pandemic: experience of the Systemic Lupus International Collaborating Clinics.

Ann Rheum Dis. 2021 Feb;80(2):1-2. doi: 10.1136/annrheumdis-2020-218164. Epub 2020 Jun 25.

Comment on 'Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19' by Konig . Long-term exposure to hydroxychloroquine or chloroquine and the risk of hospitalisation with COVID-19: a nationwide, observational cohort study in 54 873 exposed individuals and 155 689 matched unexposed individuals in France.

Ann Rheum Dis. 2023 May;82(5):e117. doi: 10.1136/annrheumdis-2020-218647. Epub 2020 Aug 28.

Hydroxychloroquine, TTP, COVID-19, and SLE.

Turk J Haematol. 2021 Feb 25;38(1):99-100. doi: 10.4274/tjh.galenos.2021.2020.0770. Epub 2021 Jan 6.

Potential of chloroquine and hydroxychloroquine to treat COVID-19 causes fears of shortages among people with systemic lupus erythematosus.

Nat Med. 2020 May;26(5):632. doi: 10.1038/s41591-020-0853-0.

Hydroxychloroquine shortages during the COVID-19 pandemic.

Ann Rheum Dis. 2021 Mar;80(3):e31. doi: 10.1136/annrheumdis-2020-217835. Epub 2020 May 20.

Cyclosporine may reduce the risk of symptomatic COVID-19 in patients with systemic lupus erythematosus: a retrospective cohort study.

Microbiol Spectr. 2024 Nov 5;12(11):e0127624. doi: 10.1128/spectrum.01276-24. Epub 2024 Oct 15.

Clinical course of COVID-19 in patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine.

Ann Rheum Dis. 2021 Apr;80(4):e54. doi: 10.1136/annrheumdis-2020-217847. Epub 2020 May 31.

Concerns and needs of patients with systemic lupus erythematosus regarding hydroxychloroquine supplies during the COVID-19 pandemic: results from a patient-centred survey.

Ann Rheum Dis. 2021 Apr;80(4):e52. doi: 10.1136/annrheumdis-2020-217967. Epub 2020 Jul 2.

引用本文的文献

Characteristics of COVID-19 and Impact of Disease Activity in Patients with Adult-Onset Still's Disease.

Rheumatol Ther. 2024 Feb;11(1):201-212. doi: 10.1007/s40744-023-00632-3. Epub 2024 Jan 6.

Evaluating Risk: Benefit Ratio of Fat-Soluble Vitamin Supplementation to SARS-CoV-2-Infected Autoimmune and Cancer Patients: Do Vitamin-Drug Interactions Exist?

Life (Basel). 2022 Oct 20;12(10):1654. doi: 10.3390/life12101654.

COVID-19 in patients with systemic lupus erythematosus: A systematic review.

Lupus. 2022 May;31(6):684-696. doi: 10.1177/09612033221093502. Epub 2022 Apr 5.

Epidemiology and Clinical Management of Rheumatic Autoimmune Diseases in the COVID-19 Pandemic: A Review.

Front Med (Lausanne). 2021 Aug 19;8:725226. doi: 10.3389/fmed.2021.725226. eCollection 2021.

Clinical outcomes of COVID-19 in patients with rheumatic diseases: A systematic review and meta-analysis of global data.

Autoimmun Rev. 2021 Apr;20(4):102778. doi: 10.1016/j.autrev.2021.102778. Epub 2021 Feb 18.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验